Tumor Board

Accreditation

The American Thyroid Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™

The American Thyroid Association designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Information

In accordance with the ACCME Accreditation Criteria, the American Thyroid Association ensures that anyone in a position to control the content of the educational activity (planners/speakers/authors/discussants/moderators) disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”) held in the last 24 months. The faculty have nothing to disclose.

The ACCME also requires that ATA manage any reported relevant financial relationships and eliminate the potential for bias during the educational activity. Any relevant financial relationships noted have been mitigated. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.

David Shonka: Nothing to disclose

Sarah Mayson: Nothing to disclose

Sara Ahmadi: Veracyte (Research Funding)

Nicole Massoll: Interspace Diagnostic (Consultant)

Francis Worden: Eisai (Advisory Board); Merck (Consultant); Bayer, Exelexis (Advisory Board)

Michael Yeh: Nothing to disclose